These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 27640009)
1. Regioselective C-H hydroxylation of omeprazole sulfide by Bacillus megaterium CYP102A1 to produce a human metabolite. Jang HH; Ryu SH; Le TK; Doan TT; Nguyen TH; Park KD; Yim DE; Kim DH; Kang CK; Ahn T; Kang HS; Yun CH Biotechnol Lett; 2017 Jan; 39(1):105-112. PubMed ID: 27640009 [TBL] [Abstract][Full Text] [Related]
2. Regioselective hydroxylation of omeprazole enantiomers by bacterial CYP102A1 mutants. Ryu SH; Park BY; Kim SY; Park SH; Jung HJ; Park M; Park KD; Ahn T; Kang HS; Yun CH Drug Metab Dispos; 2014 Sep; 42(9):1493-7. PubMed ID: 25008345 [TBL] [Abstract][Full Text] [Related]
3. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium. Cha GS; Ryu SH; Ahn T; Yun CH Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047 [TBL] [Abstract][Full Text] [Related]
4. Generation of human chiral metabolites of simvastatin and lovastatin by bacterial CYP102A1 mutants. Kim KH; Kang JY; Kim DH; Park SH; Park SH; Kim D; Park KD; Lee YJ; Jung HC; Pan JG; Ahn T; Yun CH Drug Metab Dispos; 2011 Jan; 39(1):140-50. PubMed ID: 20962060 [TBL] [Abstract][Full Text] [Related]
5. Highly regioselective hydroxylation of polydatin, a resveratrol glucoside, for one-step synthesis of astringin, a piceatannol glucoside, by P450 BM3. Le TK; Jang HH; Nguyen HT; Doan TT; Lee GY; Park KD; Ahn T; Joung YH; Kang HS; Yun CH Enzyme Microb Technol; 2017 Feb; 97():34-42. PubMed ID: 28010771 [TBL] [Abstract][Full Text] [Related]
6. Selective hydroxylation of highly branched fatty acids and their derivatives by CYP102A1 from Bacillus megaterium. Budde M; Morr M; Schmid RD; Urlacher VB Chembiochem; 2006 May; 7(5):789-94. PubMed ID: 16566047 [TBL] [Abstract][Full Text] [Related]
7. The Versatile Biocatalyst of Cytochrome P450 CYP102A1: Structure, Function, and Engineering. Sun Y; Huang X; Osawa Y; Chen YE; Zhang H Molecules; 2023 Jul; 28(14):. PubMed ID: 37513226 [TBL] [Abstract][Full Text] [Related]
8. Generation of the human metabolite piceatannol from the anticancer-preventive agent resveratrol by bacterial cytochrome P450 BM3. Kim DH; Ahn T; Jung HC; Pan JG; Yun CH Drug Metab Dispos; 2009 May; 37(5):932-6. PubMed ID: 19237510 [TBL] [Abstract][Full Text] [Related]
9. Role of residue 87 in substrate selectivity and regioselectivity of drug-metabolizing cytochrome P450 CYP102A1 M11. Vottero E; Rea V; Lastdrager J; Honing M; Vermeulen NP; Commandeur JN J Biol Inorg Chem; 2011 Aug; 16(6):899-912. PubMed ID: 21567268 [TBL] [Abstract][Full Text] [Related]
10. Computational redesign of cytochrome P450 CYP102A1 for highly stereoselective omeprazole hydroxylation by UniDesign. Huang X; Sun Y; Osawa Y; Chen YE; Zhang H J Biol Chem; 2023 Aug; 299(8):105050. PubMed ID: 37451479 [TBL] [Abstract][Full Text] [Related]
11. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis. Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513 [TBL] [Abstract][Full Text] [Related]
12. Generation of human metabolites of 7-ethoxycoumarin by bacterial cytochrome P450 BM3. Kim DH; Kim KH; Kim DH; Liu KH; Jung HC; Pan JG; Yun CH Drug Metab Dispos; 2008 Nov; 36(11):2166-70. PubMed ID: 18669587 [TBL] [Abstract][Full Text] [Related]
13. Stereoselective hydroxylation of isophorone by variants of the cytochromes P450 CYP102A1 and CYP101A1. Dezvarei S; Lee JHZ; Bell SG Enzyme Microb Technol; 2018 Apr; 111():29-37. PubMed ID: 29421034 [TBL] [Abstract][Full Text] [Related]
14. Enzymatic Production of 3-OH Phlorizin, a Possible Bioactive Polyphenol from Apples, by Nguyen NA; Cao NT; Nguyen THH; Ji JH; Cha GS; Kang HS; Yun CH Antioxidants (Basel); 2021 Aug; 10(8):. PubMed ID: 34439575 [TBL] [Abstract][Full Text] [Related]
16. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities. Yun CH; Kim KH; Kim DH; Jung HC; Pan JG Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492 [TBL] [Abstract][Full Text] [Related]
17. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency. Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686 [TBL] [Abstract][Full Text] [Related]
18. Semirational Protein Engineering of CYP153AM.aq. -CPRBM3 for Efficient Terminal Hydroxylation of Short- to Long-Chain Fatty Acids. Notonier S; Gricman Ł; Pleiss J; Hauer B Chembiochem; 2016 Aug; 17(16):1550-7. PubMed ID: 27251775 [TBL] [Abstract][Full Text] [Related]
19. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies. Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729 [TBL] [Abstract][Full Text] [Related]
20. Process development for the production of 15β-hydroxycyproterone acetate using Bacillus megaterium expressing CYP106A2 as whole-cell biocatalyst. Kiss FM; Lundemo MT; Zapp J; Woodley JM; Bernhardt R Microb Cell Fact; 2015 Mar; 14():28. PubMed ID: 25890176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]